Lee Balefsky

As the partner heading up Kline & Specter’s Mass Tort Department, Lee B. Balefsky is involved in lawsuits dealing with a wide range of products and toxic substances, from pharmaceuticals such as Vioxx to defective medical devices, from asbestos to denture creams containing zinc.

Balefsky’s Mass Tort Department at Kline & Specter was recently named in Best Law Firms in the nation following a survey conducted by U.S. News Media Group and Best Lawyers. The "Tier 1" designation was awarded to only 22 law firms in the United States and was announced in the October 2010 issue of U.S. News & World Report.

Balefsky's three decades of experience in complex litigation puts him at the forefront of Mass Torts, a burgeoning area of the law whose genesis can be traced only as far back as the late 1960s and “mass accident” claims (generally airline mishaps) and to “Agent Orange” claims that arose in the 1970s over the herbicide used in the Vietnam War.

Balefsky has been active in mass tort claims in recent years involving asbestos and, most commonly today, pharmaceuticals and faulty medical devices such as transvaginal mesh surgical products. He currently serves as Plaintiff's Liaison Counsel in Philadelphia Vioxx litigation.

Balefsky's experience helped earn him a spot among “The Best Attorneys in Pennsylvania” as

selected by Super Lawyers magazine for 10 straight years, 2004 - 2013. He was also selected for the latest edition (2013) of Best Lawyers in America.

Mass tort practice requires knowledge and the ability to handle several issues simultaneously, with cases often filed in both state and federal courts and with multiple plaintiffs and defendants. Clients are individually represented in mass tort cases but the system allows for centralizing and sharing of information, such as documents and depositions, among various parties in trials and settlement negotiations.

Balefsky’s department at Kline & Specter is currently representing clients in claims against the makers of prescription and over-the-counter medicines as well as cases involving asbestos, medical devices and MBTE, a gasoline additive that has been found to have polluted community water supplies.

In addition to his lead role with Philadelphia Vioxx cases, Balefsky has been named Philadelphia Mass Tort Program Liaison Counsel in cases targeting the diet drugs commonly known as Fen-Phen, as well as for cases involving PPA, an ingredient used in over-the-counter cold remedies. In that liaison role, he aids the court in case management while providing other attorneys with information in the various cases.

Balefsky’s Mass Tort Department recently obtained significant settlements in lawsuits against the makers of Baycol, Fen-Phen and PPA.

His department also is involved in claims involving Vioxx, Celebrex, Bextra, Ephedra, and Atypical Antipsychotic medications including Zyprexa and Risperdal.

Over the past two decades, Balefsky has won numerous cases, particularly those in which clients were found to have contracted cancer because of their exposure to asbestos, a substance which still poses a danger to the general public and, most commonly, to workers at aging factories and facilities.

Balefsky is a member of the Plaintiff’s Steering Committee in Pennsylvania Diet Drug Litigation. He has lectured extensively in the area of pharmaceutical litigation. Balefsky is board certified in civil litigation by the National Board of Trial Advocacy. He is an active member of the American Association for Justice, the Pennsylvania Association for Justice and the Philadelphia Trial Lawyers Association.

A graduate of Temple University in 1974 and Wake Forest University Law School in 1977, Balefsky has been admitted to practice in the U.S. District Eastern and Middle Districts of Pennsylvania as well in the U.S. Third Circuit Court of Appeals and the U.S. Supreme Court.

To contact Lee Balefsky, email him at